Closed Solicitation · DEPARTMENT OF VETERANS AFFAIRS

    MALDI BIOTYPER SIRIUS CA

    DEPARTMENT OF VETERANS AFFAIRS
    Sol. 36C26026Q0635Sources SoughtVANCOUVER, WA
    Closed
    STATUS
    Closed
    closed May 11, 2026
    POSTED
    May 5, 2026
    Publication date
    NAICS CODE
    334516
    Primary industry classification
    PSC CODE
    6640
    Product & service classification

    AI Summary

    The Department of Veterans Affairs is conducting a Sources Sought Announcement for a MALDI Mass Spectrometry system for microbial identification. The system must be FDA-approved and capable of identifying microorganisms from patient samples, adhering to CLIA and CLSI standards. Responses are sought from interested businesses capable of providing this technology.

    Contract details

    Solicitation No.
    36C26026Q0635
    Notice Type
    Sources Sought
    Posted Date
    May 5, 2026
    Response Deadline
    May 11, 2026
    NAICS Code
    334516AI guide
    PSC / Class Code
    6640
    Primary Contact
    Nick Heintz
    State
    WA
    ZIP Code
    98662
    AI Product/Service
    product

    Description

    This is a SOURCES SOUGHT ANNOUNCEMENT ONLY.  It is neither a solicitation announcement nor a request for proposals or quotes and does not obligate the Government to award a contract.  Responses to this Sources Sought Announcement must be in writing.  The purpose of this Sources Sought Announcement is for market research to make appropriate acquisition decisions and to gain knowledge of potential businesses interested and capable of providing the services described below.

    Background:

    The Puget Sound VA Medical Center, located in Seattle, WA is seeking a contractor to provide a MALDI (Matrix-Assisted Laser Desorption Ionization) Mass Spectrometry (Microbial Identification System). The contractor shall provide an FDA-approved automated testing system that identifies microorganisms using Matrix Assisted Laser Desorption Ionization Mass. The testing system must include the instrumentation necessary to identify common microorganisms encountered in clinically relevant patient samples through analyses of protein fingerprint spectra from Gram negative and Gram positive bacteria, yeast and fungi from any patient specimen source suspected of bacterial or fungal infection. The testing system must be able to meet the performance characteristics for accuracy and precision as defined by the 1988 Clinical Laboratory Improvement Act (CLIA) and the Clinical and Laboratory Standards Institute (CLSI). 

    (See Attached SSN 36C26026Q0635) 

    Key dates

    1. May 5, 2026Posted Date
    2. May 11, 2026Proposals / Responses Due

    AI search tags

    Frequently asked questions

    MALDI BIOTYPER SIRIUS CA is a federal acquisition solicitation issued by DEPARTMENT OF VETERANS AFFAIRS. Review the full description, attachments, and submission requirements on SamSearch before the response deadline.

    SamSearch Platform

    Stop searching. Start winning.

    AI-powered intelligence for the right opportunities, the right leads, and the right time.